Annual Cash & Cash Equivalents
$263.96 M
+$189.83 M+256.09%
31 December 2023
Summary:
Chemed annual cash & cash equivalents is currently $263.96 million, with the most recent change of +$189.83 million (+256.09%) on 31 December 2023. During the last 3 years, it has risen by +$101.28 million (+62.26%). CHE annual cash & cash equivalents is now at all-time high.CHE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$238.45 M
+$15.55 M+6.98%
30 September 2024
Summary:
Chemed quarterly cash and cash equivalents is currently $238.45 million, with the most recent change of +$15.55 million (+6.98%) on 30 September 2024. Over the past year, it has increased by +$65.30 million (+37.71%). CHE quarterly cash and cash equivalents is now -23.90% below its all-time high of $313.35 million, reached on 31 March 2024.CHE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHE Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +256.1% | +37.7% |
3 y3 years | +62.3% | +729.6% |
5 y5 years | +5363.8% | +2530.2% |
CHE Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +702.4% | -23.9% | +2964.5% |
5 y | 5 years | at high | +5363.8% | -23.9% | +3772.2% |
alltime | all time | at high | >+9999.0% | -23.9% | >+9999.0% |
Chemed Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $238.45 M(+7.0%) |
June 2024 | - | $222.90 M(-28.9%) |
Mar 2024 | - | $313.35 M(+18.7%) |
Dec 2023 | $263.96 M(+256.1%) | $263.96 M(+52.4%) |
Sept 2023 | - | $173.15 M(+8.3%) |
June 2023 | - | $159.92 M(+175.5%) |
Mar 2023 | - | $58.05 M(-21.7%) |
Dec 2022 | $74.13 M(+125.3%) | $74.13 M(+852.7%) |
Sept 2022 | - | $7.78 M(-19.3%) |
June 2022 | - | $9.64 M(-46.9%) |
Mar 2022 | - | $18.16 M(-44.8%) |
Dec 2021 | $32.90 M(-79.8%) | $32.90 M(+14.4%) |
Sept 2021 | - | $28.74 M(-68.8%) |
June 2021 | - | $92.12 M(-56.2%) |
Mar 2021 | - | $210.16 M(+29.2%) |
Dec 2020 | $162.68 M(+2541.7%) | $162.68 M(+44.3%) |
Sept 2020 | - | $112.77 M(+453.4%) |
June 2020 | - | $20.38 M(-29.6%) |
Mar 2020 | - | $28.95 M(+370.1%) |
Dec 2019 | $6.16 M(+27.5%) | $6.16 M(-32.1%) |
Sept 2019 | - | $9.07 M(+172.8%) |
June 2019 | - | $3.32 M(-62.1%) |
Mar 2019 | - | $8.77 M(+81.5%) |
Dec 2018 | $4.83 M(-56.6%) | $4.83 M(-92.8%) |
Sept 2018 | - | $67.46 M(+432.5%) |
June 2018 | - | $12.67 M(-7.4%) |
Mar 2018 | - | $13.69 M(+23.1%) |
Dec 2017 | $11.12 M(-27.4%) | $11.12 M(-41.1%) |
Sept 2017 | - | $18.87 M(+37.2%) |
June 2017 | - | $13.75 M(-70.8%) |
Mar 2017 | - | $47.05 M(+207.3%) |
Dec 2016 | $15.31 M(+4.0%) | $15.31 M(-28.1%) |
Sept 2016 | - | $21.29 M(+21.8%) |
June 2016 | - | $17.47 M(+14.7%) |
Mar 2016 | - | $15.23 M(+3.4%) |
Dec 2015 | $14.73 M(+4.2%) | $14.73 M(-61.7%) |
Sept 2015 | - | $38.45 M(+17.6%) |
June 2015 | - | $32.70 M(+15.4%) |
Mar 2015 | - | $28.34 M(+100.5%) |
Dec 2014 | $14.13 M(-83.3%) | $14.13 M(-23.9%) |
Sept 2014 | - | $18.56 M(-33.5%) |
June 2014 | - | $27.91 M(-29.3%) |
Mar 2014 | - | $39.48 M(-53.2%) |
Dec 2013 | $84.42 M(+21.4%) | $84.42 M(+1.5%) |
Sept 2013 | - | $83.20 M(-26.4%) |
June 2013 | - | $113.05 M(+55.0%) |
Mar 2013 | - | $72.96 M(+4.9%) |
Dec 2012 | $69.53 M(+82.6%) | $69.53 M(+0.3%) |
Sept 2012 | - | $69.30 M(+15.6%) |
June 2012 | - | $59.97 M(+75.3%) |
Mar 2012 | - | $34.21 M(-10.2%) |
Dec 2011 | $38.08 M(-23.7%) | $38.08 M(+78.4%) |
Sept 2011 | - | $21.34 M(-58.1%) |
June 2011 | - | $50.94 M(-14.7%) |
Mar 2011 | - | $59.74 M(+19.7%) |
Dec 2010 | $49.92 M(-55.6%) | $49.92 M(-63.7%) |
Sept 2010 | - | $137.46 M(+26.0%) |
June 2010 | - | $109.08 M(-2.7%) |
Mar 2010 | - | $112.12 M(-0.3%) |
Dec 2009 | $112.42 M(+2998.6%) | $112.42 M(+167.4%) |
Sept 2009 | - | $42.05 M(+152.8%) |
June 2009 | - | $16.63 M(+40.2%) |
Mar 2009 | - | $11.86 M(+226.9%) |
Dec 2008 | $3.63 M(-27.3%) | $3.63 M(-46.7%) |
Sept 2008 | - | $6.80 M(+346.2%) |
June 2008 | - | $1.52 M(-94.9%) |
Mar 2008 | - | $29.70 M(+495.5%) |
Dec 2007 | $4.99 M(-83.0%) | $4.99 M(-70.2%) |
Sept 2007 | - | $16.73 M(+124.0%) |
June 2007 | - | $7.47 M(-75.2%) |
Mar 2007 | - | $30.14 M(+2.9%) |
Dec 2006 | $29.27 M | $29.27 M(+440.7%) |
Sept 2006 | - | $5.41 M(-20.6%) |
June 2006 | - | $6.82 M(-85.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2006 | - | $45.67 M(-20.1%) |
Dec 2005 | $57.13 M(-20.0%) | $57.13 M(+52.1%) |
Sept 2005 | - | $37.58 M(+110.3%) |
June 2005 | - | $17.87 M(+108.8%) |
Mar 2005 | - | $8.56 M(-88.0%) |
Dec 2004 | $71.45 M(+41.0%) | $71.45 M(+39.4%) |
Sept 2004 | - | $51.26 M(-2.6%) |
June 2004 | - | $52.64 M(+22.3%) |
Mar 2004 | - | $43.04 M(-15.1%) |
Dec 2003 | $50.69 M(+34.3%) | $50.69 M(-30.2%) |
Sept 2003 | - | $72.61 M(+60.1%) |
June 2003 | - | $45.34 M(+3.9%) |
Mar 2003 | - | $43.63 M(+15.6%) |
Dec 2002 | $37.73 M(+332.4%) | $37.73 M(+141.8%) |
Sept 2002 | - | $15.60 M(+36.2%) |
June 2002 | - | $11.46 M(-21.5%) |
Mar 2002 | - | $14.59 M(+67.2%) |
Dec 2001 | $8.72 M(-15.1%) | $8.72 M(-56.7%) |
Sept 2001 | - | $20.15 M(+59.6%) |
June 2001 | - | $12.62 M(-15.1%) |
Mar 2001 | - | $14.86 M(+44.6%) |
Dec 2000 | $10.28 M(-40.6%) | $10.28 M(+26.1%) |
Sept 2000 | - | $8.15 M(-43.9%) |
June 2000 | - | $14.52 M(+5.0%) |
Mar 2000 | - | $13.82 M(-20.1%) |
Dec 1999 | $17.30 M(-58.2%) | $17.30 M(-14.4%) |
Sept 1999 | - | $20.20 M(-10.6%) |
June 1999 | - | $22.60 M(-32.7%) |
Mar 1999 | - | $33.60 M(-18.8%) |
Dec 1998 | $41.40 M(-41.7%) | $41.40 M(-17.4%) |
Sept 1998 | - | $50.10 M(-7.2%) |
June 1998 | - | $54.00 M(-25.8%) |
Mar 1998 | - | $72.80 M(+2.5%) |
Dec 1997 | $71.00 M(+407.1%) | $71.00 M(-46.0%) |
Sept 1997 | - | $131.50 M(+960.5%) |
June 1997 | - | $12.40 M(-30.3%) |
Mar 1997 | - | $17.80 M(+27.1%) |
Dec 1996 | $14.00 M(-27.1%) | $14.00 M(+1.4%) |
Sept 1996 | - | $13.80 M(-57.3%) |
June 1996 | - | $32.30 M(-23.1%) |
Mar 1996 | - | $42.00 M(+118.8%) |
Dec 1995 | $19.20 M(+308.5%) | $19.20 M(+106.5%) |
Sept 1995 | - | $9.30 M(+4550.0%) |
June 1995 | - | $200.00 K(-87.5%) |
Mar 1995 | - | $1.60 M(-66.0%) |
Dec 1994 | $4.70 M(-67.8%) | $4.70 M(-70.1%) |
Sept 1994 | - | $15.70 M(+51.0%) |
June 1994 | - | $10.40 M(-18.8%) |
Mar 1994 | - | $12.80 M(-12.3%) |
Dec 1993 | $14.60 M(+0.7%) | $14.60 M(+10.6%) |
Sept 1993 | - | $13.20 M(-50.9%) |
June 1993 | - | $26.90 M(-2.9%) |
Mar 1993 | - | $27.70 M(+91.0%) |
Dec 1992 | $14.50 M(+145.8%) | $14.50 M(-78.0%) |
Sept 1992 | - | $65.80 M(+2532.0%) |
June 1992 | - | $2.50 M(+177.8%) |
Mar 1992 | - | $900.00 K(-84.7%) |
Dec 1991 | $5.90 M(+321.4%) | $5.90 M(+268.8%) |
Sept 1991 | - | $1.60 M(+300.0%) |
June 1991 | - | $400.00 K(-69.2%) |
Mar 1991 | - | $1.30 M(-7.1%) |
Dec 1990 | $1.40 M(-62.2%) | $1.40 M(-39.1%) |
Sept 1990 | - | $2.30 M(-28.1%) |
June 1990 | - | $3.20 M(+45.5%) |
Mar 1990 | - | $2.20 M(-40.5%) |
Dec 1989 | $3.70 M(-15.9%) | $3.70 M(+27.6%) |
Sept 1989 | - | $2.90 M(+61.1%) |
June 1989 | - | $1.80 M(+80.0%) |
Mar 1989 | - | $1.00 M(-77.3%) |
Dec 1988 | $4.40 M(-6.4%) | $4.40 M(-6.4%) |
Dec 1987 | $4.70 M(-81.6%) | $4.70 M(-81.6%) |
Dec 1986 | $25.50 M(+311.3%) | $25.50 M(+311.3%) |
Dec 1985 | $6.20 M(+244.4%) | $6.20 M(+244.4%) |
Dec 1984 | $1.80 M | $1.80 M |
FAQ
- What is Chemed annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Chemed?
- What is Chemed annual cash & cash equivalents year-on-year change?
- What is Chemed quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Chemed?
- What is Chemed quarterly cash and cash equivalents year-on-year change?
What is Chemed annual cash & cash equivalents?
The current annual cash & cash equivalents of CHE is $263.96 M
What is the all time high annual cash & cash equivalents for Chemed?
Chemed all-time high annual cash & cash equivalents is $263.96 M
What is Chemed annual cash & cash equivalents year-on-year change?
Over the past year, CHE annual cash & cash equivalents has changed by +$189.83 M (+256.09%)
What is Chemed quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CHE is $238.45 M
What is the all time high quarterly cash and cash equivalents for Chemed?
Chemed all-time high quarterly cash and cash equivalents is $313.35 M
What is Chemed quarterly cash and cash equivalents year-on-year change?
Over the past year, CHE quarterly cash and cash equivalents has changed by +$65.30 M (+37.71%)